{"SPADE_UN_22677": {"Sequence Information": {"Peptide Name": "pept_1303", "Sequence": "IGRHFKRRNSIWGICWF", "Sequence Length": 17, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "A0A1D2SQC6", "uniprotUrl": "http://www.uniprot.org/uniprot/A0A1D2SQC6", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}, {"uniprotId": "A0A2S0XP88", "uniprotUrl": "http://www.uniprot.org/uniprot/A0A2S0XP88", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.", "Pubmed ID": "32992666", "Reference": "Int J Mol Sci. 2020;21:E7141", "Author": "Grafskaia EN, Pavlova ER, Babenko VV, Latsis IA, Malakhova M, Lavrenova V, Bashkirov PV, Belousov D, Klinov DV, Lazarev VN", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32992666"}], "Mass": 2176.55, "PI": 11.71, "Net Charge": 5, "Hydrophobicity": -0.35, "Frequent Amino Acids": "IRF", "Absent Amino Acids": "ADELMOPQTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 11, "Positive Residues": 5, "Negative Residues": 0, "SPADE ID": "SPADE_UN_22677", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_02584", "Similarity": 0.7777777777777778, "Sequence": "GMRHFKWGI"}, {"SPADE_ID": "SPADE_UN_05530", "Similarity": 0.5555555555555556, "Sequence": "KKRRFKRRY"}, {"SPADE_ID": "SPADE_UN_09508", "Similarity": 0.5, "Sequence": "KRKFHEKHHSHRGYCCYGRHSHHKEHFKRK"}], "Hemolytic Activity": "Mouse fibroblasts McCoy:75% Killing=59.2 µM", "Target Organism": "Escherichia coli K12 MG1655(MIC=14.8µM),Bacillus subtilis 168 HT(MIC=14.8µM),Staphylococcus aureus ST88(MIC=>100µM),Staphylococcus haemolyticus 527(MIC=14.8µM)"}}}